| Mr Michael Preston, LPC | |
|
940 Ebenezer Blvd, Madison, MS 39110-6002 | |
| (321) 480-5000 | |
| Not Available |
| Full Name | Mr Michael Preston |
|---|---|
| Gender | Male |
| Speciality | Counselor - Professional |
| Location | 940 Ebenezer Blvd, Madison, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336658756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 001182 (New York) | Secondary |
| 101YP2500X | Counselor - Professional | 2198 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Preston, LPC 416 Decelle St, Jackson, MS 39216-3103 Ph: (321) 480-5000 | Mr Michael Preston, LPC 940 Ebenezer Blvd, Madison, MS 39110-6002 Ph: (321) 480-5000 |
News Archive
As Republicans gear up to present their 2012 budget proposal, it has been revealed that the new budget would cut more than $4 trillion from federal spending projected over the next decade and transform the Medicare health program for the elderly.
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute, led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells of the Urology Service of Bellvitge University Hospital, show the usefulness of certain molecules, the miRNAs in semen, as non-invasive biomarkers for prostate cancer.
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
The study commissioned by Friends of the Earth (FoE) has found that six out of six infant formula samples tested contained nanoparticles, which are believed by FoE to be harmful. However the potential health risks of nanoparticles are disputed by others, who claim there is insufficient evidence to support this.
› Verified 2 days ago
Abigail Campbell, P-LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 940 Ebenezer Blvd, Madison, MS 39110 Phone: 601-790-0583 | |
Kendyl Hensley, BA, MDIV Counselor Medicare: Not Enrolled in Medicare Practice Location: 940 Ebenezer Blvd, Madison, MS 39110 Phone: 601-790-0583 | |
Mrs. Clara Newton, MS, PLPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 505 Cobblestone Ct Ste A, Madison, MS 39110 Phone: 601-540-7422 | |
Breda Faye Hall, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1531 Highland Colony Pkwy, Madison, MS 39110 Phone: 601-506-1459 | |
Dr. Gregory Obert, PH.D., LCPC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7570 Old Canton Rd Ste 102, Madison, MS 39110 Phone: 601-809-5324 | |
Katherine Johnson, PLPC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 208 Key Dr Ste C, Madison, MS 39110 Phone: 601-760-2050 | |
Mrs. Pamela Graef Luckett, Counselor Medicare: Not Enrolled in Medicare Practice Location: 109 Cedar Pine Ln, Madison, MS 39110 Phone: 601-214-8160 Fax: 601-856-6356 |